Is there a role for verapamil beyond rate control in paroxysmal atrial fibrillation?

This editorial refers to ‘Rate control drugs differ in the prevention of progression of atrial fibrillation’ by T. Koldenhof et al., doi:10.1093/europace/euab191. Two decades ago, several landmark studies evaluated rhythm vs. rate control strategies in patients presenting with predominantly persistent atrial fibrillation (AF). As compared to rate control, restoration and maintenance of sinus rhythm by means of antiarrhythmic drug therapy did not...